CVR: 36393459
DKK 1,000,033
Gross profit
Net result: DKK 1,883,876
Eignarhaldsfélagið Lyng ehf
CVR · view ownership and management
Director role ended: Peter Popowicz
CVR · 01/11/2016
View the full event history
ICEPHARMA A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Hörður Þórhallsson. The company is owned by Eignarhaldsfélagið Lyng ehf. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,000,033 and a net result of DKK 1,883,876 compared with DKK -3,562,543 the year before. Equity in the 2025 report amounted to DKK 10,304,500.
Source: annual report 2025, Danish Business Authority
The financial health of ICEPHARMA A/S shows a significant turnaround in 2025, with a gross profit of 1,000,033 DKK and a profit of 1,883,876 DKK, contrasting sharply with previous years of losses. From 2021 to 2024, the company faced declining gross profits and increasing losses, peaking at -5,428,101 DKK in 2023. However, the equity position has improved dramatically from 689,794 DKK in 2021 to 10,304,500 DKK in 2025, indicating a strong recovery and potential for future growth. Despite the lack of disclosed revenue figures, the substantial increase in profitability and equity suggests a positive trajectory within the medicinal wholesale industry.
AI-generated summary · Generated 14/08/2026
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1 mio. | 1.9 mio. | 11.6 mio. | 10.3 mio. | 5 | |
| 202401/01/2024 – 31/12/2024 | -410 t. | -3.6 mio. | 5.1 mio. | 3.7 mio. | 5 | |
| 202301/01/2023 – 31/12/2023 | -2.2 mio. | -5.4 mio. | 4.7 mio. | 2.2 mio. | 5 | |
| 202201/01/2022 – 31/12/2022 | -1 mio. | -4.7 mio. | 3.5 mio. | 1.6 mio. | 5 | |
| 202101/01/2021 – 31/12/2021 | -2.4 mio. | -5.4 mio. | 2.9 mio. | 690 t. | 5 | |
| 202001/01/2020 – 31/12/2020 | -2.2 mio. | -5.7 mio. | 1.8 mio. | 7 t. | 5 | |
| 201901/01/2019 – 31/12/2019 | -3.9 mio. | -7.7 mio. | 1.8 mio. | 581 t. | 5 | |
| 201801/01/2018 – 31/12/2018 | -3.6 mio. | -7.2 mio. | 2.1 mio. | 829 t. | 5 | |
| 201701/01/2017 – 31/12/2017 | -722 t. | -4.8 mio. | 598 t. | -579 t. | 6 | |
| 201601/01/2016 – 31/12/2016 | 2.2 mio. | -3.8 mio. | 1.5 mio. | 188 t. | 5 |
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningICEPHARMA A/S was founded on 30 September 2014.
ICEPHARMA A/S is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
ICEPHARMA A/S had 5 employees in 2018 according to the Danish CVR register.
ICEPHARMA A/S is owned by Eignarhaldsfélagið Lyng ehf.
icepharma.dk belongs to ICEPHARMA A/S, CVR number 36393459.
In 2025, ICEPHARMA A/S reported a gross profit of DKK 1,000,033.
Claim this page to add your logo and social links. Free to get started.
ICEPHARMA A/S has published its annual report for 2025. Gross profit came to DKK 1,000,033, and the net result was DKK 1,883,876.
ICEPHARMA A/S has published its annual report for 2024. Gross profit came to DKK -409,891, and the net result was DKK -3,562,543.
ICEPHARMA A/S has published its annual report for 2023. Gross profit came to DKK -2,175,526, and the net result was DKK -5,428,101.
ICEPHARMA A/S has published its annual report for 2022. Gross profit came to DKK -1,025,961, and the net result was DKK -4,748,115.
ICEPHARMA A/S has published its annual report for 2021. Gross profit came to DKK -2,436,032, and the net result was DKK -5,423,874.
ICEPHARMA A/S has published its annual report for 2020. Gross profit came to DKK -2,207,233, and the net result was DKK -5,660,020.
ICEPHARMA A/S has published its annual report for 2019. Gross profit came to DKK -3,925,725, and the net result was DKK -7,690,041.
ICEPHARMA A/S has published its annual report for 2018. Gross profit came to DKK -3,628,386, and the net result was DKK -7,235,141.
ICEPHARMA A/S has published its annual report for 2017. Gross profit came to DKK -721,994, and the net result was DKK -4,846,949.
As of June 1, 2017, Petrea Ingileif Gudmundsdottir has joined the board of directors of ICEPHARMA A/S.
As of June 1, 2017, Jóhann Ingi Kristjánsson has joined the board of directors of ICEPHARMA A/S.
As of June 1, 2017, Margrét Guðmundsdóttir has left the board of directors of ICEPHARMA A/S.
As of June 1, 2017, Bessi Húnfjörð Jóhannesson has left the board of directors of ICEPHARMA A/S.
As of November 1, 2016, Hörður Þórhallsson is registered as director of ICEPHARMA A/S.
As of November 1, 2016, Peter Popowicz has stepped down as director of ICEPHARMA A/S.
ICEPHARMA A/S has published its interim report for the period September 30, 2014 – December 31, 2015.
As of September 30, 2014, KPMG P/S has been appointed auditor of ICEPHARMA A/S.
As of September 30, 2014, Kristján Johannsson has joined the board of directors of ICEPHARMA A/S.
As of September 30, 2014, Margrét Guðmundsdóttir has joined the board of directors of ICEPHARMA A/S.
As of September 30, 2014, Bessi Húnfjörð Jóhannesson has joined the board of directors of ICEPHARMA A/S.
As of September 30, 2014, Peter Popowicz is registered as director of ICEPHARMA A/S.
As of September 30, 2014, is registered as an owner of ICEPHARMA A/S with an ownership share of 100%.
ICEPHARMA A/S was founded on September 30, 2014.
Companies in the same industry and area
CVR 20247371
CVR 36445335
CVR 67036514
CVR 79091812
CVR 37005665
